4CPS-228 Effectiveness and security of new direct-acting antiviral agents for hcv

BACKGROUND: New direct-acting antivirals (DAAs) for chronic hepatitis C have been marketed and have changed the therapeutic landscape of this pathology. PURPOSE: To assess the effectiveness and security of new direct-acting antiviral agents for HCV. MATERIAL AND METHODS: Retrospective study carried...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: Marín, L Martínez Dueñas López, González, E González, Bonilla, AManzano, Romero, ACaballero, Sacristán, EGalindo, Chica, FMalpica, Romera, MCamacho
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 4: Clinical pharmacy services
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535611/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.318
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia